Effect of a novel phyto-compound on mucosal candidiasis: Further evidence from an ex vivo study

Journal of Digestive Diseases

Volumn 8, Issue 1, 2007, Pages 48-51

  Nakajima, Juntaro ^a,b   Papaah, Pete ^a,b   Yoshizawa, Masako ^c   Marotta, Francesco ^d   Nakajima, Teriyuki ^a   Mihara, Shin ^c   Minelli, Emilio ^d  

^a Nakajima Dental Clinic   (Japan)

^b Umuntiwar Community Clinic   (India)

^c Oral Biology and Bioregulator Laboratory   (Japan)

^d UNIVERSITY OF MILAN   (Italy)

Author keywords

Ex vivo; Kolorex; MCP 1; Oral candidiasis; Saliva

Indexed keywords

EID: 84876032031     PISSN: 17512972     EISSN: 17512980     Source Type: Journal    
DOI: 10.1111/j.1443-9573.2007.00283.x     Document Type: Article

References (17)

1. Ruhnke M. Epidemiology of Candida albicans infections and role of non-Candida-albicans yeasts. Curr Drug Targets 2006; 7: 495-504.
2. Chakrabarti A. Microbiology of systemic fungal infections. J Postgrad Med 2005; 51 (Suppl.): S16-S20. 3 Molero G, Diez-Orejas R, Navarro-Garcia F et al. Candida albicans: genetics, dimorphism and pathogenicity. Int Microbiol 1998; 1: 95-106.
3. Molero G, Diez-Orejas R, Navarro-Garcia F et al. Candida albicans: genetics, dimorphism and pathogenicity. Int Microbiol 1998; 1: 95-106.
4. Staib P, Michel S, Kohler G, Morschhauser J. A molecular genetic system for the pathogenic yeast Candida dubliniensis. Gene 2000; 242: 393-8.
5. Mavor AL, Thewes S, Hube B. Systemic fungal infections caused by Candida species: epidemiology, infection process and virulence attributes. Curr Drug Targets 2005; 6: 863-74. 6 Muzyka BC. Oral fungal infections. Dent Clin North Am 2005; 49: 49-65.
6. Muzyka BC. Oral fungal infections. Dent Clin North Am 2005; 49: 49-65.
7. Arkell S, Shinnick A. Update on oral candidosis. Nurs Times 2003; 99: 52-3.
8. Kubo I, Himejima M. Anethole, a synergist of polygodial against filamentous microorganisms. J Agric Food Chem 1991; 39: 2290-2.
9. Himejima M, Kubo I. Antifungal activity of polygodial in combination with anethole and indole against Candida albicans. J Agric Food Chem 1993; 41: 1776-9.
10. Mori T, Ando J. Diagnostic tests: candidiasis (candidosis). Nippon Rinsho 2005; 63 (Suppl 7): 241-3.
11. Polonelli L, Morace G. A microautomated dilution method for susceptibility testing with antifungal drugs. Mycopathologia 1984; 86: 21-8.
12. Leenders AC, de Marie S. The use of lipid formulations of amphotericin B for systemic fungal infections. Leukemia 1996; 10: 1570-5.
13. Davenport JC. The oral distribution of Candida in denture stomatitis. Br Dent J 1970; 129: 151-6.
14. Rindum JL, Stenderup A, Holmstrup P. Identification of Candida albicans types related to healthy and pathological oral mucosa. J Oral Pathol Med 1994; 23: 406-12.
15. Burtner. Effects of chlorhexidine spray on plaque and gingival health in institutionalized persons with mental retardation. Special Care Dentistry 1991; 11: 97-100.
16. Naito Y, Wu CC, Seal MG et al. Protective effect of a polygodial/anethole-containing natural product against candida albicans gastrointestinal colonization and dissemination. Int Med J 2001; 8: 3-9.
17. Marotta F, Barreto R, Kawakita S et al. Protein-calorie malnutrition is an aggravating factor of ischemia-reperfusion - induced Candida translocation through the gut: preventive effect of a phyto-therapeutic compound. Chin J Dig Dis 2006; 7: 33-8.